Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799676937> ?p ?o ?g. }
- W2799676937 endingPage "2719" @default.
- W2799676937 startingPage "2711" @default.
- W2799676937 abstract "Background and aims Omega-3 fatty acids (FA) can ameliorate the hyper-inflammatory response that occurs in conditions such as severe acute pancreatitis (SAP) and this may improve clinical outcome. We tested the hypothesis that parenteral omega-3 FA from a lipid emulsion that includes fish oil could be beneficial in patients with predicted SAP by reducing C-reactive protein (CRP) concentration (primary outcome), and modulating the inflammatory response and improving clinical outcome (secondary outcomes). Methods In a phase II randomized double-blind single-centre controlled trial, patients with predicted SAP were randomised to receive a daily infusion of fish oil containing lipid emulsion (Lipidem® 20%, BBraun) for 7 days (n = 23) or a daily infusion of a lipid emulsion without fish oil (Lipofundin® MCT 20%, BBraun) (n = 22). Results On admission, both groups had comparable pancreatitis predicted severity and APACHE II scores. Administration of fish oil resulted in lower total blood leukocyte number (P = 0.04), CRP (P = 0.013), interleukin-8 (P = 0.05) and intercellular adhesion molecule 1 (P = 0.01) concentrations, multiple organ dysfunction score, sequential organ failure assessment score (P = 0.004), early warning score (P = 0.01), and systemic inflammatory response syndrome (P = 0.03) compared to the control group. The fish oil group had fewer new organ failures (P = 0.07), lower critical care admission rate (P = 0.06), shorter critical care stay (P = 0.03) and shorter total hospital stay (P = 0.04). Conclusions It is concluded that intravenous administration of a fish oil containing lipid emulsion, a source of omega-3 FA, improves clinical outcomes in patients with predicted SAP, benefits that may be linked to reduced inflammation. ClinicalTrials.gov number NCT01745861. EU Clinical Trials Register EudraCT (2010-018660-16). Omega-3 fatty acids (FA) can ameliorate the hyper-inflammatory response that occurs in conditions such as severe acute pancreatitis (SAP) and this may improve clinical outcome. We tested the hypothesis that parenteral omega-3 FA from a lipid emulsion that includes fish oil could be beneficial in patients with predicted SAP by reducing C-reactive protein (CRP) concentration (primary outcome), and modulating the inflammatory response and improving clinical outcome (secondary outcomes). In a phase II randomized double-blind single-centre controlled trial, patients with predicted SAP were randomised to receive a daily infusion of fish oil containing lipid emulsion (Lipidem® 20%, BBraun) for 7 days (n = 23) or a daily infusion of a lipid emulsion without fish oil (Lipofundin® MCT 20%, BBraun) (n = 22). On admission, both groups had comparable pancreatitis predicted severity and APACHE II scores. Administration of fish oil resulted in lower total blood leukocyte number (P = 0.04), CRP (P = 0.013), interleukin-8 (P = 0.05) and intercellular adhesion molecule 1 (P = 0.01) concentrations, multiple organ dysfunction score, sequential organ failure assessment score (P = 0.004), early warning score (P = 0.01), and systemic inflammatory response syndrome (P = 0.03) compared to the control group. The fish oil group had fewer new organ failures (P = 0.07), lower critical care admission rate (P = 0.06), shorter critical care stay (P = 0.03) and shorter total hospital stay (P = 0.04). It is concluded that intravenous administration of a fish oil containing lipid emulsion, a source of omega-3 FA, improves clinical outcomes in patients with predicted SAP, benefits that may be linked to reduced inflammation." @default.
- W2799676937 created "2018-05-17" @default.
- W2799676937 creator A5003816957 @default.
- W2799676937 creator A5020137820 @default.
- W2799676937 creator A5027108487 @default.
- W2799676937 creator A5028912750 @default.
- W2799676937 creator A5030880551 @default.
- W2799676937 creator A5040877786 @default.
- W2799676937 creator A5042813132 @default.
- W2799676937 creator A5063642392 @default.
- W2799676937 creator A5066362474 @default.
- W2799676937 creator A5073887589 @default.
- W2799676937 creator A5074645101 @default.
- W2799676937 creator A5074471733 @default.
- W2799676937 date "2020-09-01" @default.
- W2799676937 modified "2023-10-06" @default.
- W2799676937 title "Intravenous omega-3 fatty acids are associated with better clinical outcome and less inflammation in patients with predicted severe acute pancreatitis: A randomised double blind controlled trial" @default.
- W2799676937 cites W1898500983 @default.
- W2799676937 cites W1898928487 @default.
- W2799676937 cites W1964842374 @default.
- W2799676937 cites W1971916080 @default.
- W2799676937 cites W1973194788 @default.
- W2799676937 cites W1975689390 @default.
- W2799676937 cites W1983390737 @default.
- W2799676937 cites W1985045980 @default.
- W2799676937 cites W1991193659 @default.
- W2799676937 cites W1993799487 @default.
- W2799676937 cites W1994833668 @default.
- W2799676937 cites W2000537420 @default.
- W2799676937 cites W2044880240 @default.
- W2799676937 cites W2052184365 @default.
- W2799676937 cites W2065324716 @default.
- W2799676937 cites W2079284050 @default.
- W2799676937 cites W2085208748 @default.
- W2799676937 cites W2087203965 @default.
- W2799676937 cites W2088147907 @default.
- W2799676937 cites W2094826033 @default.
- W2799676937 cites W2105472550 @default.
- W2799676937 cites W2114841940 @default.
- W2799676937 cites W2118704546 @default.
- W2799676937 cites W2120853814 @default.
- W2799676937 cites W2133757652 @default.
- W2799676937 cites W2133839928 @default.
- W2799676937 cites W2143969656 @default.
- W2799676937 cites W2144891204 @default.
- W2799676937 cites W2145758369 @default.
- W2799676937 cites W2151172513 @default.
- W2799676937 cites W2155327124 @default.
- W2799676937 cites W2160599911 @default.
- W2799676937 cites W2163053953 @default.
- W2799676937 cites W2293743168 @default.
- W2799676937 cites W2416077315 @default.
- W2799676937 cites W2768146862 @default.
- W2799676937 cites W4251281915 @default.
- W2799676937 cites W63127804 @default.
- W2799676937 doi "https://doi.org/10.1016/j.clnu.2018.04.003" @default.
- W2799676937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32921364" @default.
- W2799676937 hasPublicationYear "2020" @default.
- W2799676937 type Work @default.
- W2799676937 sameAs 2799676937 @default.
- W2799676937 citedByCount "9" @default.
- W2799676937 countsByYear W27996769372017 @default.
- W2799676937 countsByYear W27996769372021 @default.
- W2799676937 countsByYear W27996769372022 @default.
- W2799676937 countsByYear W27996769372023 @default.
- W2799676937 crossrefType "journal-article" @default.
- W2799676937 hasAuthorship W2799676937A5003816957 @default.
- W2799676937 hasAuthorship W2799676937A5020137820 @default.
- W2799676937 hasAuthorship W2799676937A5027108487 @default.
- W2799676937 hasAuthorship W2799676937A5028912750 @default.
- W2799676937 hasAuthorship W2799676937A5030880551 @default.
- W2799676937 hasAuthorship W2799676937A5040877786 @default.
- W2799676937 hasAuthorship W2799676937A5042813132 @default.
- W2799676937 hasAuthorship W2799676937A5063642392 @default.
- W2799676937 hasAuthorship W2799676937A5066362474 @default.
- W2799676937 hasAuthorship W2799676937A5073887589 @default.
- W2799676937 hasAuthorship W2799676937A5074471733 @default.
- W2799676937 hasAuthorship W2799676937A5074645101 @default.
- W2799676937 hasBestOaLocation W27996769372 @default.
- W2799676937 hasConcept C126322002 @default.
- W2799676937 hasConcept C168563851 @default.
- W2799676937 hasConcept C2775967933 @default.
- W2799676937 hasConcept C2776252253 @default.
- W2799676937 hasConcept C2776376669 @default.
- W2799676937 hasConcept C2776670229 @default.
- W2799676937 hasConcept C2776914184 @default.
- W2799676937 hasConcept C2778384902 @default.
- W2799676937 hasConcept C2779946292 @default.
- W2799676937 hasConcept C2780347030 @default.
- W2799676937 hasConcept C2780835948 @default.
- W2799676937 hasConcept C2781090800 @default.
- W2799676937 hasConcept C2909208804 @default.
- W2799676937 hasConcept C505870484 @default.
- W2799676937 hasConcept C535046627 @default.
- W2799676937 hasConcept C71924100 @default.
- W2799676937 hasConcept C78722104 @default.
- W2799676937 hasConcept C86803240 @default.
- W2799676937 hasConcept C90924648 @default.